re: 3 biotech winners for 2006 SRX has very large price appreciation potential from $2 to $7, already underway as Australian govt is now financing Sir Spheres which could add 100 milllion to revenues and 25 million NET of profit or extra 50 cents in earnings and Sp is only 2 NOW.
